Association between duration of neoadjuvant hormonal therapy and prostate-specific antigen response and pathological outcomes in high-risk prostate cancer undergoing robot-assisted radical prostatectomy
Frontiers in Oncology · 20.04.2026 · 16
DOI: 10.3389/fonc.2026.1817402 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 20.04.2026. Verfasst von Jingsuo Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Soochow University, Department of Urology, Suzhou, Jiangsu, China. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Program of Suzhou.
Abstract (Originalsprache)
Purpose
The optimal duration of neoadjuvant hormonal therapy (NHT) for high-risk prostate cancer remains controversial. In this study, we evaluated the association between NHT duration and prostate-specific antigen (PSA) kinetics as well as pathological outcomes in patients who underwent extraperitoneal robot-assisted radical prostatectomy.
Methods
We retrospectively analyzed the data of 72 patients with high-risk prostate cancer who received NHT followed by extraperitoneal robot-assisted radical prostatectomy with pelvic lymph node dissection at a tertiary hospital in 2025. Patients were stratified into the short-term (NHT, ≤3 months; n=41) and long-term (NHT, >3 months; n=31) groups. PSA response, pathological features, and perioperative outcomes were compared between the two groups.
Results
The PSA nadir was significantly lower in patients who underwent long-term NHT than in those who underwent short-term NHT (median 0.02 vs. 0.23 ng/mL). The proportions of patients in whom PSA levels of <0.1 ng/mL (67.74% vs. 29.27%) and <0.2 ng/mL (83.87% vs. 41.46%) were achieved were significantly higher in the long-term group. Pathological analyses demonstrated a significantly lower incidence of extraprostatic extension in patients undergoing long-term NHT (38.71% vs. 70.73%). Operative time and intraoperative blood loss were similar between the groups.
Conclusion
In patients with high-risk prostate cancer, undergoing NHT for longer than 3 months was associated with greater suppression of PSA and more favorable pathological outcomes. Particularly, we observed a reduced incidence of extraprostatic extension and no increase in perioperative morbidity. Achieving a substantial PSA response during NHT may be useful as an indicator for optimizing the timing of surgical intervention.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Affiliated Hospital of Soochow University, Department of Urology, Suzhou, Jiangsu, China.
- The First People's Hospital of Jintan, Department of Urology, Changzhou, Jiangsu, China.
- The First Affiliated Hospital of Soochow University, Department of Nephrology, Suzhou, Jiangsu, China.
Förderung
- Science and Technology Program of Suzhou
Zitieren
APA
Wang, J., Wu, Y., Zhang, C., Ouyang, J., Zhang, F., & Zhang, Z. (2026). Association between duration of neoadjuvant hormonal therapy and prostate-specific antigen response and pathological outcomes in high-risk prostate cancer undergoing robot-assisted radical prostatectomy. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1817402
Vancouver
Wang J, Wu Y, Zhang C, Ouyang J, Zhang F, Zhang Z. Association between duration of neoadjuvant hormonal therapy and prostate-specific antigen response and pathological outcomes in high-risk prostate cancer undergoing robot-assisted radical prostatectomy. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1817402
BibTeX
@article{Wang2026,
author = {Wang, Jingsuo and Wu, Yunfeng and Zhang, Chuanao and Ouyang, Jun and Zhang, Fan and Zhang, Zhiyu},
title = {Association between duration of neoadjuvant hormonal therapy and prostate-specific antigen response and pathological outcomes in high-risk prostate cancer undergoing robot-assisted radical prostatectomy},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1817402}
}
EUVIMED